Skip to content

Acute Effects of Whole-body Vibration Training in Hypoxia and Normoxia in Multiple Sclerosis Patients

Acute Effects of Whole-body Vibration Training in Hypoxia and Normoxia Condition on Neuromuscular Performance and Mobility in Patients With Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03856801
Enrollment
13
Registered
2019-02-27
Start date
2018-06-15
Completion date
2018-08-30
Last updated
2019-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

neuromuscular disease, whole-body vibration, hypoxia, strength

Brief summary

Multiple Sclerosis (ME) is a degenerative, inflammatory and autoimmune demyelinating disease of the central nervous system, characterized by demyelination due to inflammation and degeneration of the myelin sheaths enveloping nerves of the eye, periventricular grey matter, brain, spinal cord and brainstem. The symptoms associated with MS include symptomatic fatigue, muscle weakness, ataxia, mobility and balance problems or cognitive problems. Moderate intensity strength training has been shown to improve strength and mobility in persons with MS. It was suggested that whole-body vibration training (WBVT) is effective to improve muscle strength, such as resistance training, resulting from both neural and structural adaptations. On the other hand, traditional strength training in hypoxia has garnered much attention. This method has shown improvements in isometric strength and increases in muscle size.

Detailed description

* Crossover. * 13 patients with multiple sclerosis were recruited. * Patients performed two sessions: whole-body vibration training in normoxia condition and whole-body vibration in hypoxia condition.

Interventions

OTHERExercise

Whole-body vibration training in hypoxia and normoxia condition

Sponsors

Universidad Católica San Antonio de Murcia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* mild or moderate disability with clinical mild spastic-ataxic gait disorder. * stable phase of the disease.

Exclusion criteria

* Expanded Disability Status Scale (EDSS) \< 6. * relapsing disease within the preceding 12 months. * corticosteroid treatment within the last months before study inclusion.

Design outcomes

Primary

MeasureTime frameDescription
SpasticityImmediately before the training sessionsPendulum test
Maximal Voluntary Isometric Contraction of Knee ExtensionImmediately before the training sessions
Rate of Force DevelopmentImmediately before the training sessions
Central Activation RatioImmediately before the training sessions
Biomechanical study of the walk by video recordingImmediately before the training sessionsKinematic analysis of knee and ankle angles during walking

Secondary

MeasureTime frameDescription
Walking speedImmediately before the training sessionsTest 10 m-walks
Static balanceImmediately before the training sessionsRomberg Test with eyes open and closed. Analysis with force plates
Muscle oxygenation in soleusImmediately before the training sessionsMOXY's
Rate of Perceived ExertionImmediately before the training sessionsRPE Scale 6-20

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026